Atlas / Search, productivity and consumer / OpenEvidence
OpenEvidence
AI Market Atlas · by Pro Pluribus
US
The AI answer engine for clinicians, free to doctors and ad-funded; used by 40%+ of US physicians (company figure); reportedly valued at $15B.
Missed in the September build; added in the October update. Withdrew from the EU and UK in April 2026.
What it offers
Main offerings
- OpenEvidence search
- Evidence-based clinical answers; voice mode and EHR integration.
- Learn
- Free personalised medical education platform (4 Nov).
Recent news
- OpenEvidence launches Learn, a free personalised medical education platformIts first product beyond clinical search.OpenEvidence ↗
- NYU Langone partners with OpenEvidence across 12 million patient visitsA large health-system deployment of patient-aware AI.OpenEvidence ↗
- OpenEvidence reportedly raises $250M at a $15B valuationUp from $12B in January; reportedly fielding acquisition interest (unconfirmed by the company).AI Weekly (Business Insider) ↗
This map is a by-product of the work. Keeping track of what each of these actually does, and which ones are worth your time, is part of how I advise founder-led companies on AI. If you want that applied to your business, the first conversation is free.
Book a 30-minute conversation →Compiled from public sources by Pro Pluribus; updated 10 Nov 2026. General information, not advice. Company names and logos belong to their owners and are used to identify them, without affiliation or endorsement. Terms